Elicio Therapeutics Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 26.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -26.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 911.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 237.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 1,129.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -1,155.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 20.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -1,201.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -3.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -1,201.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -1,154.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.